Table 1 Biological potency.

From: Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column

ADCC

Protein

EC50 (μg/mL)

Relative potency (%), 95% confidence interval

Rituximab

0.13

100

Peak 1

0.20

80 (70.4~92.9)

Peak 2

0.19

84 (74.0~97.6)

Peak 3

0.05

146 (128.0~168.0)

CDC

 

EC 50 (μg/mL)

Relative Potency (%), 95% confidence interval

Rituximab

2.3

100

Peak 1

5.0

45 (40.3~52.0)

Peak 2

2.8

80 (70.8~91.2)

Peak 3

1.9

117 (104.0~134.1)